1-10 of 10
Mariano Arribas
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Proteogenomic Approach to Identify Potential Drivers of Hyperdiploid Multiple Myeloma

J Erin Wiedmeier-Nutor, Surendra Dasari, Richard Kumaran Kandasamy, Kiran Manalaparthi, Laura Ann Bruins, Gregory Ahmann, Mariano Arribas, P. Leif Bergsagel, Akhilesh Pandey, Esteban Braggio, Rafael Fonseca
Journal: Blood
Blood (2024) 144 (Supplement 1): 3269.
https://doi.org/10.1182/blood-2024-206239
Published: 2024
Journal Articles

Pre-Infusion Ferritin: A Predictive Biomarker for CAR T-Cell Therapy Response in Multiple Myeloma

Eider Moreno, Mariano Arribas, David A. Martinez, Juana Figueroa Aguirre, Rohan S Patel, Udit Yadav, Erin J Wiedmeier-Nutor, Leif Bergsagel, Rafael Fonseca, Saurabh Chhabra, Januario E. Castro
Journal: Blood
Blood (2024) 144 (Supplement 1): 7096.
https://doi.org/10.1182/blood-2024-211376
Published: 2024
Journal Articles

Beyond the Primary: Unveiling the Prognostic Value of Secondary Cytogenetic Abnormalities in Multiple Myeloma

Rodrigo Fonseca, Mariano Arribas, Gregory Ahmann, Janna C Castro, Erin E Wiedmeier-Nutor, Linda Banovic Baughn, P. Leif Bergsagel, Rafael Fonseca
Journal: Blood
Blood (2023) 142 (Supplement 1): 2000.
https://doi.org/10.1182/blood-2023-190701
Published: 2023
Journal Articles

Electrocardiogram As a Marker of Cardiac Response in Light Chain Amyloidosis

Rodrigo Fonseca, Yael Kusne, Mariano Arribas, Molly Klanderman, Julia E. Wiedmeier, Eli Muchtar, P. Leif Bergsagel, Craig B. Reeder, Jeremy T. Larsen, Rafael Fonseca, Julie L Rosenthal
Journal: Blood
Blood (2022) 140 (Supplement 1): 12566–12567.
https://doi.org/10.1182/blood-2022-168083
Published: 2022
Journal Articles

Cyclophosphamide-Bortezomib-Dexamethasone (CyBorD) +/- Daratumumab Treatment Results in Sustained Hematologic Response in Patients with AL Amyloidosis: A Retrospective Analysis of Patients at Mayo Clinic

Yael Kusne, Rodrigo Fonseca, Mariano Arribas, Molly Klanderman, Julia E. Wiedmeier, Craig B. Reeder, Jeremy T. Larsen, P. Leif Bergsagel, Julie L Rosenthal, Rafael Fonseca
Journal: Blood
Blood (2022) 140 (Supplement 1): 7224–7225.
https://doi.org/10.1182/blood-2022-166668
Published: 2022
Journal Articles

Newly Diagnosed, Untreated, Multiple Myeloma (MM) Patient Samples Already Harbor Cereblon (CRBN) Exon 10 Deletions Associated with Drug Resistance

Yuan Xiao Zhu, Gregory J Ahmann, Laura Ann Bruins, Mariano Arribas, Xianfeng Chen, Marta Chesi, P. Leif Bergsagel, Rafael Fonseca, Lisa M. Rimsza
Journal: Blood
Blood (2022) 140 (Supplement 1): 4187–4188.
https://doi.org/10.1182/blood-2022-157316
Published: 2022
Journal Articles

A Single Next Generation Sequencing Assay for Detection of Driver Mutations, Translocations and Copy Number Alterations in Patients with Multiple Myeloma

Cecilia Bonolo De Campos, James B Smadbeck, Mariano Arribas, Neeraj Sharma, Gregory J Ahmann, Shaji K Kumar, A. Keith Stewart, Rafael Fonseca, P. Leif Bergsagel, Yan Asmann, Linda B. Baughn, Esteban Braggio
Journal: Blood
Blood (2022) 140 (Supplement 1): 7180–7181.
https://doi.org/10.1182/blood-2022-170749
Published: 2022
Journal Articles

Identifying Mechanisms Associated with Venetoclax Resistance in Multiple Myeloma (MM)

Yuan Xiao Zhu, Laura Ann Bruins, Joseph Ahmann, Cecilia Bonolo De Campos, Esteban Braggio, Xianfeng Chen, Mariano Arribas, Susie Darvish, Gregory J Ahmann, Rafael Fonseca
Journal: Blood
Blood (2021) 138 (Supplement 1): 2668.
https://doi.org/10.1182/blood-2021-153747
Published: 2021
Journal Articles

Measles, Mumps & Rubella Titers Post Autologous Stem Cell Transplant in Multiple Myeloma Patients Induced with Modern Therapy

Mariano Arribas, Gregory J Ahmann, BS, Skye Buckner-Petty, MPH, Esteban Braggio, PhD, Elitza S Theel, PhD, Rafael Fonseca, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 43.
https://doi.org/10.1182/blood-2020-142616
Published: 2020
Journal Articles

Improving the Definition of Response Assessment: Prognostic Value of Minimal Residual Disease Combined with PET/CT at Day 100 Post Autologous Stem Cell Transplantation in Multiple Myeloma

Miguel Gonzalez-Velez, MD, Mariano Arribas, Heidi E. Kosiorek, MS, Richard Butterfield, III, Carlo Guerrero, MD, Luke Mountjoy, DO, Jeremy Larsen, Craig B. Reeder, MD, P. Leif Bergsagel, MD, A. Keith Stewart, MB, ChB, Rafael Fonseca, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 33–34.
https://doi.org/10.1182/blood-2020-142845
Published: 2020